Attached files

file filename
10-Q - FORM 10-Q - CATALYST BIOSCIENCES, INC.d10q.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - CATALYST BIOSCIENCES, INC.dex311.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - CATALYST BIOSCIENCES, INC.dex312.htm
EX-10.1 - COLLABORATIVE RESEARCH AND LICENSE AGREEMENT - CATALYST BIOSCIENCES, INC.dex101.htm
EX-10.2 - SIXTH LEASE AMENDMENT - CATALYST BIOSCIENCES, INC.dex102.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - CATALYST BIOSCIENCES, INC.dex321.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Targacept, Inc. (the “Company”) for the period ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan A. Musso, Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 9, 2010  

/s/ Alan A. Musso

  Alan A. Musso
  Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer